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Careless talk costs
grants
Alan Akers
The editors of Current Biology really
should be more careful; some
contributors are in danger of giving
the game away. Years of careful
fostering of the idea that everything
can be explained in terms of
molecular genetics and structural
biology — thus keeping many of us
gainfully employed — may have been
undermined by their careless
revelations. The current ascendancy
of these disciplines could be at risk if
information so casually made available
should fall into the wrong hands.
Usually, you play your role
exceptionally well. Unqualified
assertions that genetic studies of
aggressiveness in mice could “. . . be
directly applicable to our
understanding of human nature”
slipped into the literature without a
ripple [1]. Sydney Brenner’s
suggestion that, because some viral
gene products combine in a fixed
proportion, “it is possible to encode a
mathematical rule in DNA” [2] —
with the logical extrapolation that if
he, a mere bundle of gene products,
jumped out of the window, his DNA
would implicitly encode the law of
gravity — gave genome studies the
opportunity to annex half the funds
for chemical and physical research.
Then there was the statement about
the yeast genome, worthy of a Star
Trek script, “. . . it encourages us to
pursue the goal that has been implicit
from the beginning: the complete
understanding of how a eukaryotic
cell functions. The attainment of this
lofty goal now seems possible” [3].
Virtual biology and surfing the
genomes was all set to abolish the
need for messy, wet experiments,
which don’t always work and, when
they do, have a regrettable tendency
to throw up untidy, unexpected
results. Many of us were looking
forward to seeing out our entire
research careers with a few clicks on
the mouse and a sheaf of publications
liberally seeded with comments such
as ‘intriguing conserved sequence
motif’, ‘could suggest’, ‘might imply’
and (my favourite) ‘putative receptor’.
But, just when half the world was
convinced that every problem from
constipation to criminality is rooted
in the base sequence of DNA, you
allow loose talk such as “. . . almost
any protein domain can bind inositol
phosphate if required” [4] to slip
through. Furthermore, the authors
openly admit to “. . . the variety of
domains that can bind inositol
phosphates”, and make things even
worse by conceding that “. . . the
functions of most of the binding sites
are not yet clear”.
Every research scientist using low
molecular weight, biologically active
compounds soon becomes aware that
almost any protein domain can bind
almost anything under the right
circumstances, but most are
instinctively discreet about it. If the
promiscuous tendencies of proteins
and the sheer variability of biological
systems became widely appreciated,
ignorant, unscrupulous journalists
could call into question our ability to
predict the behaviour of living
systems from their DNA sequences
and protein structures. The fig-leaf
of a priori reasoning could be
shamelessly stripped away to reveal
vulgar post hoc rationalization.
We can only hope that the relaxed
style of Current Biology and the
speculative license it allows to its
contributors have not attracted critical
readers from outside the profession.
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Warthog and
Groundhog, novel
families related to
Hedgehog
Thomas R. Bürglin
Cell–cell signalling is one of the
fundamental mechanisms by which
different cell fates are generated
during development. One group of
signalling molecules, encoded by the
Drosophila gene hedgehog and its
vertebrate orthologues, has been
shown to play important roles during
development of flies and vertebrates
(see [1–3]). Searching through the
Caenorhabditis elegans genome, a
major fraction of which has now been
sequenced [4], reveals several
sequences with similarities to
hedgehog genes. The similarity is
restricted to the carboxyl terminus of
the Hedgehog proteins, which is
surprising given that the amino-
terminal part, which provides the
biologically active signal, is more
highly conserved between fly and
vertebrate Hedgehogs. The carboxyl
terminus is a distinct domain that has
autoproteolytic activity and cleaves
Hedgehog into a protease domain
and a signalling part [5–7], and it is
thought to regulate the release of the
amino-terminal signal (see [8]).
The carboxy-terminal domain,
which I refer to here as the ‘Hog’
domain, is about 200–250 amino
acids long. Figures 1 and 2a show an
alignment of the Hog domains of
various Hedgehogs from flies and
vertebrates, as well as the predicted
products of several of the new 
C. elegans genes. The level of
sequence similarity between the 
C. elegans and Hedgehog sequences
is of the order of 22–32 % identity in
this domain, with highly significant
scores produced by BLAST database
searches [9]. The probability of a
chance match of the ZK678 Hog
domain to Drosophila Hedgehog is
4.2 × 10–7. A search of Genbank with
the Hog domain has not revealed
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any other genes encoding this
domain.
The autoproteolytic cleavage site
in Hedgehog is at a conserved
Cys–Phe pair (see arrow, Fig. 2a)
within the Hog domain [5], and
these two residues are conserved in
the C. elegans Hog domains. The
cleavage site was also predicted by
computer comparison to the amino-
terminal splice sites of ‘intein’
protein domains, which are spliced
out of larger precursor proteins [10];
the N′-terminal splice junction motif
for intein proteins (block A, Fig. 2a)
matches all Hog domains. A second
weak similarity to intein sequence
block B [11] is also observed in the
Hog domain (Fig. 2a), but the rest of
the Hog domain has no further
similarity with inteins.
Novel domains associated with Hog 
As the Hog domain is located at the
carboxyl terminus (Fig. 1), database
searches and comparisons were
performed using the amino-terminal
parts of the same sequences; these
revealed two new motifs. The first, of
about 130–170 amino acids, for which
I propose the name ‘Wart’, is present
in eight C. elegans sequences (Fig. 2b).
There appear to be two different types
of Wart domain that differ in their
central region. Most sequences with a
Wart domain also have an associated
Hog domain, but three have not (Fig.
1). The Wart domains are highly
divergent, but their similarity is
nevertheless statistically significant.
Their high divergence allows the
identification of crucial residues:
cysteines appear to play an important
role (Fig. 2b). All Warthog sequences
have good signal sequences [12] (for
protein export) immediately upstream
of the Wart domain (Figs 1, 2b).
The second motif, for which I
propose the name ‘Ground’, is found
in nine C. elegans sequences and one
from the parasitic nematode Brugia
malayi (Fig. 2c), estimated to have
diverged from C. elegans 500 million
years ago (D. Fitch and M. Baxter,
personal communication). The
Ground domain can occur with or
without an associated Hog domain
(Figs 1, 2c), and some genes contain
multiple copies of the Ground
domain. As is the case for Wart
domains, some Ground domains are
highly divergent, most have clearly
identifiable signal sequences at their
amino termini, and some of the
conserved positions are characterized
by cysteines. (The amino-terminal
200 amino acids of T05C12.10 show
no sequence similarity to anything
else in the databases, but it too
contains several cysteines and a
signal sequence.)
Most of the genes presented here
must be functional, as cDNAs have
been found for several of them.
Because the Hog domain has so far
always been found at the carboxyl
terminus of a sequence (Fig. 1), it
seems unlikely that any protein
splicing is involved. The Hog
domain might play a role in
regulating the release of the amino-
terminal signal domain, but several
of the Warthogs and Groundhogs do
not have a Hog domain, suggesting
that it is not always required, and
that its putative regulatory role is
dispensable under certain conditions. 
The fact that most, if not all, of
the sequences have a leader motif
indicates that they are secreted
molecules. In flies and vertebrates,
the Hog domain has so far been found
only in the Hedgehog proteins, which
are involved in cell–cell signalling.
The Wart and the Ground domains
are both relatively small motifs
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Figure 1
The structure of Hedgehog proteins, the 
C. elegans and B. malayi Hog, Warthog and
Groundhog proteins. The open reading frames
(ORFs) used in Fig. 2 were either taken as
annotated by the Genome Project or analyzed
using Genefinder in ACEDB locally [17]. Local
ORF analysis, taking into account the
observed sequence similarities, occasionally
yielded results different from the annotations
by the Genome Project (such ORFs are in
quotation marks). In two cases, other genes
are inappropriately joined to Warthog genes
(ZK1290.5, an aldo/keto reductase, and
F38E4.6, a cGMP cation-gated channel
protein). In some cases (F46H5 and C04E6)
the precise 5′ end could not be determined
conclusively. For W06B11.4 the start codon is
predicted to be inside the Hog domain; the
highly conserved Cys–Phe of the protein
splice junction in Fig. 2a has been added
manually by extending the ORF towards the 5′
end, and no obvious ORF continuation was
found further upstream; perhaps W06B11.4 is
a pseudogene. It should be noted that
unfinished sequences might harbour mistakes,
possibly altering the extent of ORFs outside of
the regions of similarity. Hog domains are
black, Wart domains red, and Ground domains
blue. Protein regions enriched in particular
amino acids (labelled ‘repetitive’, marked with
grey boxes) are indicated; they are rich in
amino acids such a Gly, Ala, Gln, Pro, Thr and
combinations thereof. The arrows underneath
the ORFs indicate partial sequences from
randomly sequenced cDNAs; some genes are
only represented by cDNAs. Asterisks mark
signal sequences, and the square brackets
indicate where other open reading frames
were inappropriately joined by Genefinder. 
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characterized by conserved cysteines,
reminiscent of other signalling
molecules, such as the activin/TGF-b
family [13], the NGF-type growth
factors [14], the Wnt family [15], and
the chordin family [16]. Thus it is
possible that the new Hog family
members are novel signalling
molecules. A member has already
been found in a divergent nematode
species, so others might occur in flies
and vertebrates too. It seems likely
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Figure 2
(a) The Hog domain. Alignment of the carboxy-
terminal regions of various Hedgehog proteins
with seven open reading frames (ORFs) from
the C. elegans genome project. The regions
with similarity to intein blocks A and B are
indicated at the top. (b) Sequence alignment
of the Wart domain and associated signal
sequences. Lower case letters in cm20f10
indicate uncertain residues which result from
corrections of frameshifts and ambiguous
nucleotides to maintain protein sequence
similarity. The program MACAW [18,19] —
available at the EBI worldwide web site
(http://www.ebi.ac.uk) — was used to
determine statistical probabilities for
conserved sequence blocks: the probability of
a chance occurrence of the Wart domain is
less than 1 in e–100. (c) Sequence alignment
of the Ground domain. The cDNA yk87f2
shows extended sequence similarity to
R08B4.1 outside the Ground domain, so it
probably also contains several Ground
domains. The probability for the Ground
domain as calculated by MACAW, is also less
than 1 in e–100. Yellow boxes mark conserved
cysteines and green boxes other highly
conserved residues. The consensus at
particular positions is given on top of the
alignments: capital letters indicate an absolute
conservation, lower case letters a preferential
occurrence of that residue. Positions with less
conserved residues are marked with open
boxes, and preferred residues are given above
the alignment. Positions with small
hydrophobic residues are indicated by ø for
I,L,V,M; small and large hydrophobic residues
are marked with a Ø. Positions that are
somewhat conserved,  displaying only a
limited number of residues, are marked by a
dot (•). Circumflexes (^) indicate the putative
cleavage sites of the signal leader sequences.
Accession numbers: Drosophila melanogaster
(d) hedgehog (hh): L05404; mouse (m) Sonic
hedgehog (Shh): X76290; human (h) Shh:
L38518; chicken (c) Shh: L28099; zebrafish
(zf) Shh: Z35669; m Indian hedgehog (m Ihh):
X76291; h Ihh: L38517; m Desert hedgehog
(Dhh): X76292; Xenopus laevis (Xl) Shh-1:
L39213; B. malayi SW3ICA1195: N44358.
C. elegans genes: T05C12: Z66500;
ZK1290: U21308; R08B4: Z68008;
W06B11: U39854; cm20f10: M89293;
F52E4: U56964; F38E11: Z68342; yk87f2:
D67840 and D64725; yk66e9: D69245;
T19H9: U41746, F46H5: U41543.
Unpublished C. elegans sequences can be
obtained by ftp from ftp.sanger.ac.uk (in
/pub/C.elegans_sequences/ ), and from
http://genome.wustl.edu/gsc/gschmpg.html.
Once finished,  sequences can be retrieved
under their cosmid name using, for example,
SRS at EMBL (http://www.embl-
heidelberg.de/srs/srsc).
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ZK678       MGFAPSGLQLYYCFPGDAMVNVYNGGFKRMDELAVGDWVQALDKNGSQVTFIPVQYWLHRDPKQVADFVEFTL-DNGETFSLTEKHLVFVTQCSVP----
ZK1037      YLPAAPQCQQYYCFPNDAVVNVYEKAVKRMDELEIGDWVEALDENGEDITFLPVKYWLHRDPEQEAEFLEFSL-DNGETFTLTEKHLVYTTECRQN----
T05C12.10   GAAGAAGGGRSNCFSADSLVTTVTG-QKRMDELQIGDYVL-VPSSGNVLKYEKVEMFYHREPKTRTNFVVLYT-KSGRKLSLTGRHLLPVAECSQVEQYT
ZK1290.5    GYYYPVASGVPACFTGNSKVMTPAG-EKSMADLSVGDMVM--TYEYGKMTYTRVASWLHRLPDTKAAFIKLTT-EQGAIIDMTPQHFIYKANCVTE----
ZK377       NLNGLFGGTGMQCFSGDMEVETEDG-IKMIKDLKIGDKVL--SMDEAFVTYSPVIMFLHKRDEEIAEFNLIET-ANGHSIKLTDNHLIYVSDCRTR----
R08B4.1     NPLSALVAATGACFSLDTWVTTPTG-KKRMDQIDIGDYVL--TADLEKTYFTPITLWIHREPEKVQEFLTIMT-EYGKTLRITSRHFMYRNKCGKSYPQY
W06B11.4           TNGHACFSTDSWMTTPSG-KKRMDQVGIGDLVL--TGNLTATYYTPIITWMHREPENRYNFYTIMT-EYGKMLAVSAKHLIYRNLCDENYAEY
d hh           SSISSHVHGCFTPESTALLESGVRKPLGELSIGDRVLSMTAN-GQAVYSEVILFMDRNLEQMQNFVQLHT-DGGAVLTVTPAHLVSVWQPESQ----
m Shh          NSVAAKSGGCFPGSATVHLEQGGTKLVKDLRPGDRVLAADDQ-GRLLYSDFLTFLDRDEGAKKVFYVIETLEPRERLLLTAAHLLFVAPHNDS----
h Shh          NSVAAKSGGCFPGSATVHLEQGGTKLVKDLSPGDRVLAADDQ-GRLLYSDFLTFLDRDDGAKKVFYVIETREPRERLLLTAAHLLFVAPHNDSATGE
c Shh          NSVAAKSGGCFPGSATVHLEHGGTKLVKDLSPGDRVLAADAD-GRLLYSDFLTFLDRMDSSRKLFYVIETRQPRARLLLTAAHLLFVAPQHNQ----
zf Shh         NSVAAKSGGCFPGSALVSLQDGGQKAVKDLNPGDKVLAADSA-GNLVFSDFIMFTDRDSTTRRVFYVIETQEPVEKITLTAAHLLFVLDNSTE----
m Ihh          HSAAAKTGGCFPAGAQVRLENGERVALSAVKPGDRVLAMGED-GTPTFSDVLIFLDREPNRLRAFQVIETQDPPRRLALTPAHLLFIADNHTE----
h Ihh          HSAAAKTGGCFPAGAQVRLESGARVALSAVRPGDRVLAMGED-GSPTFSDVLIFLDREPHRLRAFQVIETQDPPRRLALTPAHLLFTADNHTE----
m Dhh          NSLAVRAGGCFPGNATVRLRSGERKGLRELHRGDWVLAADAA-GRVVPTPVLLFLDRDLQRRASFVAVETERPPRKLLLTPWHLVFAARGPAP----
Xl Shh-1       NSVAAKSGGCFPAGARVMVEFGGTKAVKDLRPGDRVLSSDPQ-GNLLYSDFLMFIDQERDVKKLFYVIETS--QRKIRLTAAHLLFVAQTKVN----
            .........|.........|.........|.........|.........|.........|.........|.........|.........|.........|
                    10        20        30        40        50        60        70        80        90       100
                               ••A  ø  g• ØØ•         Ø    ø  ø       G•ØsPøT  G øøø• ø•sSc•s ø    Ø    Ø
ZK678       --------YSEDENINANPVPAERVNIGDCFYIAHRK-KSQMYQRVKVLDINIVQK-TGIYSPMTSRGHLLVDRIHASCHSETDNYSLQNTFFTNVLRWK
ZK1037      --------SSEL-KISWESISAGKVNAGDCFYLAQSE-ALTKYRLVEILDIKRVKK-TGIYAPMTSQGHLLVNKIHTSCHSEVDHHILQNSFFKHVLKWK
T05C12.10   MN------PDGIDVAMRESKYAEKARKGECVLSIDE---SGEVIADEIVRVGRMTN-VGIYSPMTVEGSLIVDGVLSSCFSHLESHSAHKLIFDFIYYVY
ZK1290.5    ---------------EMELVYAEDMTIGDCLMVKEN----EKLVMTTISEKSTFYE-TGVYAPMTETGDLIVDDVYASCHNVVKANTLSHTFLNFATSV-
ZK377       --------------SDLKLVAAKEVKMDDCIHVTTD---SNVVIKKKVSKISKVIE-TGIYSPLTSTGDIIVNRVLASCHSNLALKSLQQTFFSLYKRTS
R08B4.1     IK---------MLPHDGEAIFASDLEVGDCVVVLYK----GKYRQQKIETITRSVR-TGIYSPLTNNGRIIVNDMLASCYSEIQQNTLQTTFFWAY----
W06B11.4    VK---------YLPKGRNVVYAEELKVGDCLVLLYK----GKFRQQRVMRISITER-KGIYAPITKNGRIIVNDIVASVFSGIKHTRLQSDYYSTI----
d hh        ---------------KLTFVFAHRIEEKNQVLVRDVE--TGELRPQRVVKLG-SVRSKGVVAPLTREGTIVVNSVAASCYAVINSQSLAHWGLAPMRLLS
m Shh       -----------GPTPGPSALFASRVRPGQRVYVVAERGGDRRLLPAAVHSVTLREEEAGAYAPLTAHGTILINRVLASCYAVIEEHSWAHRAFAPFRLAH
h Shh       PEASSGSGPPSGGALGPRALFASRVRPGQRVYVVAERDGDRRLLPAAVHSVTLSEEAAGAYAPLTAQGTILINRVLASCYAVIEEHSWAHRAFAPFRLAH
c Shh       SEAT--------GSTSGQALFASNVKPGQRVYVLGE--GGQQLLPASVHSVSLREEASGAYAPLTAQGTILINRVLASCYAVIEEHSWAHWAFAPFRLAQ
zf Shh      ------------DLHTMTAAYASSVRAGQKVMVVDD---SGQLKSVIVQRIY-TEEQRGSFAPVTAHGTIVVDRILASCYAVIEDQGLAHLAFAPARLYY
m Ihh       ------------PAAHFRATFASHVQPGQYVLVSG----VPGLQPARVAAVS-THVALGSYAPLTRHGTLVVEDVVASCFAAVADHHLAQLAFWPLRLFP
h Ihh       ------------PAARFRATFASHVQPGQYVLVAG----VPGLQPARVAAVS-THVALGAYAPLTKHGTLVVEDVVASCFAAVADHHLAQLAFWPLRLFH
m Dhh       ------------APGDFAPVFARRLRAGDSVLAPG----GDALQPARVARVA-REEAVGVFAPLTAHGTLLVNDVLASCYAVLESHQWAHRAFAPLRLLH
Xl Shh-1    ------------GTRSFKSVFASNIQPGDLIYTADPK--TMTLKAVKVEKVDL-EEDTGAYAPLTAHGTVVIDQVLASCYAVIEEHTWAHLAFAPLRFGM
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ZK678       -------------------------SQIRNYFWT----------VEDSTNEDNIGYGLNGVMAVLDIVIPSKLM
ZK1037      -------------------------NKITKYFWS---------YETERNIGQSLNSLIAIFNLVVPFFYLFLLLLSFLNFSEA
T05C12.10   NAFGLLNRAKGPAYLQAHRALRPPKYTKHVFLFFNRAFNRLIELKSNHVDLQPIPTFVSFAQYLSKTVLPFS
ZK1290.5    ------------------------QQKMRSVLGS-------------LEETGHLPATSEFFLNIIDVLLPHKY
ZK377       -------------------------SVFHNLMFFK-----------SSTEEGDLPVGVETLTSVMDLFIPQSFV
R08B4.1     -------------------------DKLRSVLVEF--------FGDLYNNKIELPTGTTLSRDIISLIVPIQK
W06B11.4    -------------------------AYAQSWLWI---------FGETVFHKATIPIGSALASDV-RLVIP
d hh        TLEAWLPAKEQLH------------SSPKVVSSAQQQ--------------NGIHWYANALYKVKDYVLPQSWRHD
m Shh       ALLAALAPARTDGGG------------GGSIPAAQ-----SATEARGAEPTAGIHWYSQLLYHIGTWLLDSETMHPLGMAVKS
h Shh       ALLAALAPARTDRGGDS-GGGDRGGGGGRVALTAP-----GAADAPGAGATAGIHWYSQLLYQIGTWLLDSEALHPLGMAVKS
c Shh       GLLAALCP-------------------DGAIPTA-------------ATTTTGIHWYSRLLYRIGSWVLDGDALHPLGMVAPA
zf Shh      YVSSFLFPQNSS---------------SRSNATLQQ---------------EGVHWYSRLLYQMGTWLLDSNMLHPLGMSVNS
m Ihh       SLA------------------------WGSWTPS-----------------EGVHSYPQMLYRLGRLLLEESTFHPLGMSGAG
h Ihh       SLA------------------------WGSWTPG-----------------EGVHWYPQLLYRLGRLLLEEGSFHPLGMSGAG
m Dhh       ALGALLP--------------------GGAVQP------------------TGMHWYSRLLYRLAEELMG
Xl Shh-1    SLSSYIYPRDSSPPSGLQPHHQVDLQSHHQVDLQSH----HQVDLQSHHQLEGIHWYSQLLYQIGTWLLDSNSLHPLGMATKS
            .........|.........|.........|.........|.........|.........|.........|.........|.........|
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ZK678            MRFSLLALVLLSSSYKFTYG^SECGDSTIPYSLEVLSSGQPILGCARPTCFGWHSNGHQLPTNAKFFRIDQQSDGFLRDDPLAIHTFDAADPRVYAQQ
cm20f10        MNYLLLVSGLLSVWQFGSQVFG^SRCGESTIPFSLEILPSGHPVLGCARpTCFGWHPKDYQLPTTAKFSRLNgnSDGFLRDDSLFTYPFETDSSKIYkSQ
ZK1037         MNISKCVLVVALLSLCCKLSFG^SSCGETTIPFSFEILPTGQPVLGCARPTCFGWDPKGYHLPTDARFVRIDRKRDGFLRDDPIYTYPFTPDGSKMYLQQ
ZK1290.5        MMVMNPLTATFLAALIGTAAS^ASCGSSGIPFRFEVLPSGQPVLGCGSPTCFGAENGGRDLRHDSSFMAGADGDDGFFRDGDLARVRVRDPDA---PAQ
F52E4.6             MHTPIIFLLALVPVALA^SYCGQSAIPYTFQVLRSGYPVLGCARPKCFGWTANGTRAGETAQFYRVAGKDDGYLRRSDQFIKSPSKNPN--FVPQ
F38E11.7          MLYHVEMFTIILLFGFSLA^DYCGSDQVPYGMEVHHSGVVRLMCSKPNCYDKN--------------------------------------------
W03D2          MCSMWLMASWLMAFVAG^STLA^DYCGDHKVPFGMEVHKNGNVNILCSRPSCHEKKYA-SDIIEISTFY----------------------------SEN
ZK377       MTLLNLFYCFCLLFGAVLA^DSIHDGGSCGTNSIPYKMEVDSEGKPVISCEAPSCLGVSSSAARRPRVL----------------------------------
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ZK678       QASCEQEFQSL-SCNPEDQWVGGIAPVMNASTTKIVAYKCCTYAPLRASIDRGVATVSG--GQIVVGGEIFAD-NKPYAFDYISNVEKKIDSEGEIFYEPQGG
cm20f10     NSTCEP...
ZK1037      NSTCEPAFQSA-MCDSKIQWVGGVEPVQDVNSTHDIAYQCCTYPPLRESTDRGMTLVAA--GQIVIGGEVFKN-GSQYAFDYISNIAKNIDEYGKIFYEVNVR
ZK1290.5    MANCPREFSSS-SCSNPMTWVGGFKA----SDNGDLSLQCCHYEGLRFAQEVGRPVVHP--GEVYSGGEVLRD-GRQTGFDAISNVRKITSGDGTVAYEVTVT
F52E4.6     LAICTDEYKSK-TCEE-GEWVGGLSP-QSDPFADQLEMKCCSYQVLISAEDRGNAIVKQ--GQLVVGGEVLDG-SRLVAFDYISNLSKSVSENGTVVYVASIK
F38E11.7    YSDCPERAESRHGCQKSNQWVGGFEK----NIEGDLYTMCCEFEGLEKYAKVRYSDVRIRRGEFFEGEEKENDDGDVVKFDVIKDIRMHKDDEGFVCSSFSN*
W03D2       SYECPERATST-TCSTNSSWVGGVTQ----HSDGSLRLMCCEYDLLPTYSTIQYEKLTIRTGEYFEGDEQMEG-DVVTAFDLIGNIEQVKEPDGKYSYNLLIY
ZK377       DVSCDPFKEI--VCVKDLQWTSGLVEI-NNGTHRTLKTECCSYEGMSDAKTIKSIFLGP--GQSFVGGMVEKD-GEQSGFDLIKEIRKTVNADNQVQYIVGVY
            ......|.........|.........|.........|.........|.........|.........|.........|.........|.........|......
                110       120       130       140       150       160       170       180       190       200
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R08B4.1 rp1 RFGNRTWVHPYQSITVECCDEELSKLIHKTILDAGNNAKLG-----NLAKFIQRRSQLFYHMSFETIVSRENFAISTHYHGTHSCRVHDNNLYYLVYETPVQYDPFNMKT
R08B4.1 rp2 RLPENTHCDKERKDGNRCCDGRLASTMRDAMRQMATSPDFGQGKEGIIAAELQQKVQQRFQKSYEIIVSQSDFVISTYTAGDNFCKFDNKGFYILAYVSPKQYDIDEKED
yk87f2-5    RYPKGTHCESGKRDGNKCCDARLAATMRDAMRQMA...
R08B4.1 rp3 AGYPVGSHCTQARTGSKCCSLILFNAMKSGYDSHVATSNFDPYDIRNISKAVQWSVEEILQHSAEVIVSLDDFAYATYNNNSYTCKYRVDKYHILAYTTPNHDLDNYDEM
R08B4.1 rp4 AKPFNCPADLSGLSGMACCDGGLQFEANKVIDQAKQEPDFDKHNTRNLAKLMTRAVQKRFGTTFESVVAEADFSWGTNKFNGRTCKIDSQGYNALTYQSSSKPPPPSDFI
T01B10      NCPSMKSRKHAKSGDLYCCDSTIKTVIKRGIRTLSYFGDDGPQTLGPIVQGLSTYVQRHYGVAYEIVLAPKGFILNSNYNGSSVCKFETNSYTMAVYETPEHYDVNGPGE
yk66e9-5    TCPSLKDRQLAKPGQLFCCDSTIKTVVETGMQTLDLFGAGGPQTLGPIVQALSTFVQEHFKTVYEIVMAPKEFVLNTHYNGISLCKFQSNSYTLVIYETQVN...
C04E6       KDTLPLQTCFHNPSGYVCCNLELNNVVESTYKEVRELPNFNPCNLQLIANKVQRASERMFGHPFESIVSHADFAQNINFSGDLVCKLEIDGNYQNRAITEVIVGVNSHEY
T18H9.1     NNTFPLPSCFYNPSGYVCCNLMLNELMSTSFEEVKVAT--NLCNVHKFATKLQKHSEKIFSTQFETIVSYQDFSQKIHFKKDLVCKIEVEGRFILAYATPEDVEQEKIIP
F46H5.6     ERNLPLKGCFYNNHGYACCNLKLQNKMEELADELLNNGTFHRCNVQKLANDLQDKVESAFKEDFETVVGLSDFAERIHFREHYVCKIEVNGRYMLAWATPDDIGTRRKRG
C37C3       PPPPPGPNCFTNPSGFLCCNVTLEKTMEDAYLAAKADG-ASLCNVQKMATAVQAQAEKKFGTTFESVAAHSDFVAKINFAGDLNCKIEIDGKFILAYATPIAEQEVNIVD
F41E6       VCFA^QDNCYINDSGFTCCNKELESAMKGAMGGDDLLG---------SADSIQKGAEGSLGGKFETVVALDDFAYKSHFKEGKSCKIEKNGQYALAWQP*
B.malayi    LNA^YREDCFINVGGYVCCDMDMVKVMQNVMEEDDNLL--------NVAKKIQDDAW-WRNAKFETVVAYDDFAYKTLFKAGKACKVSRNGMQAIN*
            .........|.........|.........|.........|.........|.........|.........|.........|.........|.........|.........|
                    10        20        30        40        50        60        70        80        90       100       110
(a)
(b)
(c)
that, in addition to Hedgehog motifs,
other motifs associated with a Hog
domain will be found in higher
animals.
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Gazetteer
British Biotech plc
What is it famous for?  Being a high-
profile biotechnology company
despite being based in the UK. It
was the first biotechnology company
to be listed on the London stock
exchange; it is now one of about 20.
How did it start? It was founded in
July 1986 by two scientists from G.D.
Searle & Co., a British
pharmaceutical company, when
Monsanto bought Searle and
promptly closed it. Keith McCullagh,
one of the founders, is now the CEO;
the other, Brian Richards, was
Chairman until the end of 1994.
What does it do?  British Biotech’s
focus from the start has been cancer
therapeutics, in particular the matrix
metalloproteinases (MMPs) that
appear to be important in tissue
invasion by malignant cells. Its most
promising product at present is an
orally active MMP inhibitor, originally
given the evocative name BB-2516
but now known as marimastat, which
is currently in phase III clinical trials
for pancreatic cancer.
Are all the company’s eggs in the
MMP basket?  No. Other drugs in
clinical trials include lexipafant, a
platelet-activating factor inhibitor
now in phase III trials for pancreatitis
and phase II for other indications, and
BB10010, an engineered version of
macrophage inflammatory protein-1a
that is intended to protect stem cells
during chemotherapy (currently in
phase II trials). Phase II trials of p24-
VLP, a “virus-like-particle” and
candidate HIV therapeutic vaccine,
proved “less than encouraging” and
were dropped.
How is the company funded?  Mostly
by stock sales; there is no income
from drugs as yet. It recently
launched a rights issue to raise £143
million (about $212 million), thought
to be the largest amount ever raised
by a biotech company. Less than half
of the shares were taken up by
existing shareholders, however; this
was disappointing, but not fatal, as
underwriters made up the difference.
Why did it need to raise more money?
Although British Biotech’s cash
reserves stood at around £66 million
before the rights issue, the company
plans extensive (and expensive)
clinical trials for both of its lead
products in the near future. The
company claims that this should be
the last time it needs to appeal to the
stock market for cash before the
money from hoped-for drug sales
starts coming in. The company also
wants to consolidate its UK operations
at a new site in Cowley, Oxford.
Does the company have any presence
in the US?  Yes. British Biotech Inc.
was founded in 1993 in Annapolis.
It’s responsible for clinical trials in
the US, and for dealing with the US
Food and Drug Administration.
Why are there so few biotechnology
companies in the UK?  British
Biotech’s success in raising money
suggests that the problem is not one of
funding. The lack of entrepreneurial
spirit in the ‘old country’ is a popular
explanation, as always; the fact that
venture capitalists are less aggressive
outside the US may also be a factor.
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